BridgeBio

Our sincerest gratitude goes out to Alex, who openly shared what life is like for her son Hudson, who is living with hypochondroplasia, a skeletal dysplasia characterized by short stature. We appreciate the awareness you are helping to raise for this important community. Listen to the full #OnRarePodcast here: https://bit.ly/3KyPj4l

This week on #BioTechNation, we discover why Dr. Neil Kumar, Founder and CEO at BridgeBio Pharma, believes genetic diseases are solvable and how their unique corporate structure fosters innovation. Listen here or wherever you download podcasts: https://lnkd.in/gXjfj_Xa

The progression of ATTR‑CM lessens people’s strength, mobility, and independence. While advancements have been made, there is still work to fulfill unmet needs for patients.

Listening to the community is a priority in learning what is important for those impacted by a condition. We are grateful to have attended this year’s Achondroplasia & Skeletal Dysplasia Research Conference hosted by The Chandler Project and look forward to applying our learnings to future collaborations with the community.

BridgeBio exists to help patients and make a difference in the lives of millions afflicted with genetic conditions. We are hiring Therapeutic Sales Specialists to join us on our mission in the East regions: New England, New York, Mid-Atlantic South Atlantic, and Northeast. Apply today: https://lnkd.in/ep3KmgM6

We're thrilled to announce our 2024 Principal Corporate Membership with BridgeBio! Our shared commitment to improving gender diversity made this an ideal strategic partnership. Together, we will work to support more women in cardiology and increase diversity in the cardiovascular field. 📖 https://bit.ly/3L4nvVF #Cardiology #WomenInCardiology 

Congenital adrenal hyperplasia (CAH) is a genetic condition that affects the ability of the adrenal glands to produce many of the body’s crucial hormones. In honor of CAH Awareness Month, Lesley shares her experiences living with CAH and how connecting with a community has allowed her to live well with CAH and provide support to others. Listen to Lesley’s story: https://bit.ly/45JtA3d

As part of this year’s Achondroplasia & Skeletal Dysplasia Research Conference hosted by The Chandler Project, Laura Guido, PharmD, MBA, BCPS, senior medical director of medical affairs at BridgeBio will be presenting recent PROPEL 2 data from our achondroplasia program and Elena Muslimova, M.D., Ph.D., medical director at BridgeBio will introduce our ACCEL program for hypochondroplasia. Learn more about the agenda: https://bit.ly/4aVSE80

We are honored to attend The Chandler Project’s Achondroplasia & Skeletal Dysplasia Research Conference, which is an amazing opportunity to come together as parents, caregivers, genetic counselors, scientific researchers, and physicians to learn more about and discuss the latest advancements in skeletal dysplasias like achondroplasia and hypochondroplasia. Learn more about the conference: https://bit.ly/4ehXhwo

In the latest episode of our #OnRarePodcast, Teja R., senior director of strategy & operations of skeletal dysplasias, discusses the hope for improvements in research for people living with hypochondroplasia. Listen: https://bit.ly/3KyPj4l